Low-Concentration Pheromone Composition for Mammal Stress
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pheromone compositions for non-human mammals are inefficient as they typically contain pheromones at high concentrations (2-10% by weight), limiting their versatility and effectiveness in various situations, and there is a need for compositions with lower pheromone amounts suitable for diverse applications.
Innovation Solution
A composition comprising pheromones in an amount of less than about 1% by weight, specifically mixtures of linoleic acid and valeric acid or their esters, combined with ethyl acetate, which is effective in treating behavioral stress problems in non-human mammals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pheromone compositions contain high concentrations of pheromones (2-10% by weight), then the effectiveness in treating behavioral stress problems is improved, but the versatility and applicability in various situations deteriorates
Solution Approach 1:
The patent changes the concentration parameter of pheromones from the conventional high range (2-10% by weight) to a low range (less than 1% by weight). This parameter change resolves the contradiction by demonstrating that low concentrations can achieve both effectiveness in treating behavioral stress problems and versatility in various applications when combined with specific carrier solvents like ethyl acetate, linoleic acid, and valeric acid.
Solution Approach 2:
The patent creates a composite composition by combining pheromones with specific carrier solvents (ethyl acetate, linoleic acid, valeric acid) in a low concentration ratio. This composite approach allows the pheromone mixture to maintain effectiveness while achieving versatility across different application scenarios, as the carrier solvents enhance delivery and stability without requiring high pheromone concentrations.
2Adaptability or versatility
If pheromone compositions are formulated with low pheromone amounts (less than 1% by weight), then the versatility and suitability for diverse applications is improved, but the effectiveness in treating behavioral stress problems deteriorates
Solution Approach 1:
The patent introduces carrier solvents (ethyl acetate, linoleic acid, valeric acid) as intermediaries that facilitate the delivery and effectiveness of low concentration pheromones. These intermediary substances enhance the bioavailability and stability of the pheromone mixture, allowing effective treatment at concentrations less than 1% by weight, thus resolving the contradiction between low amounts and effectiveness.
Solution Approach 2:
The patent modifies the concentration parameter to less than 1% by weight while maintaining effectiveness through optimized formulation parameters including the selection of specific carrier solvents and their ratios. This parameter optimization demonstrates that effectiveness can be achieved at low concentrations when other formulation parameters are properly adjusted.
Data Source
AI summary
The present invention relates to a composition of less than or equal to about 1% of pheromones useful to treat or prevent a behavioral stress problem of a non-human mammal. It also relates to a device comprising said composition and to a method for preventing and/or treating stress-related behaviors in a non-human mammal, by using said composition or device.